\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationBrussels
DG HOME has prepared a CERIS workshop, discussing security research contributions to preventing and countering corruption. The Community of European Research and Innovation for Security (CERIS) consists of practitioners, policymakers, civil society representatives and researchers relevant to the field of security research.
During this workshop, EU-funded projects will be discussed (lessons learned, latest insights, etc.). It will be held physically in Brussels, Bouche à Oreille on 22 November 2023.
Registration and agenda details can be found here. Registration is free, but mandatory.
Draft agenda:
09:00 - Registration & coffee
09:30 - Welcome address & keynote speech
10:00 - Panel 1: Tools and approaches to prevent corruption
11:30 - Coffee break
12:00 - Panel 2: Detection and investigation of corruption crime
13:30 - Lunch
14:30 - Panel 3: New and emerging challenges related to corruption
16:00 - Wrap-up & closing
16:15 - Coffee
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
